Drutz David's Form 4 filing
Altimmune, Inc. (ALT) · filed Mar 27, 2023
- Accession no.
- 0001104659-23-037190
- Filed
- Mar 27, 2023
- Trade date
- Mar 23, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $38.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Drutz DavidCIK 0001428764 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2023 | Common Stock, par value $0.0001 | PPurchaseAcquired | +9,000 | $4.27 | +$38,430 | 29,484 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.